Drug Information

Drug General Information
Drug ID
D06FQS
Former ID
DNCL003135
Drug Name
TGOF02N
Indication Schizophrenia [ICD9: 295; ICD10:F20] Phase 2 [550649]
Company
Fabre-Kramer Pharmaceuticals
Target and Pathway
Target(s) 5-HT 2 receptor Target Info Modulator [550648]
KEGG Pathway Calcium signaling pathway
Neuroactive ligand-receptor interaction
Gap junction
Serotonergic synapse
Inflammatory mediator regulation of TRP channels
References
Ref 550649Clinical pipeline report, company report or official report of Fabre-Kramer Pharmaceuticals.
Ref 550648Clinical pipeline report, company report or official report of Fabre-Kramer Pharmaceuticals.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.